Our Mission: Inspire the Development and Growth of Nucleate Leadership
For years, early-career scientists have struggled to access the mentorship, networks, and community needed to transform bold ideas into real-world impact.
Nucleate was created to ensure they never have to face that journey alone — and to provide the kind of support so many of us wish we had earlier in our own careers.
Our Challenge: leave the ladder down for the next generation of innovators during these uncertain times
To remain mission-aligned, independent, & accessible for the next 20 years, Nucleate needs a stable philanthropic foundation — built by the people who know us best: our mentors, advisors, and industry supporters.
Introducing Nucleate’s Leadership Council
A Leadership Community Shaping the Future of Nucleate
Members join a curated group of life science leaders and disruptors committed to leaving the ladder down for the next generation.
Membership Includes
Annual virtual “State of Nucleate” council meeting to help shape our organization’s future
Early exposure to standout innovation and talent across our global community
Preferred access to Nucleate events, including complimentary Summit registration
Recognition as a champion of the next generation on our website, impact report, and digital LinkedIn badge
The Leadership Council will play a critical role in sustaining the financial stability of Nucleate. We ask that you support this cause by donating $5,000 each year, or more if you can, to Nucleate as an expectation of being a member of the Leadership Council. Donations can be made anytime during the calendar year. As a 501(c)3 non-profit, your donation to Nucleate is tax deductible.
GREG ERMAN, Chairman NLC President & CEO Luzatu TherapeuticsAnn DeWitt General Partner Engine VenturesPeter Barrett Partner Atlas VentureChris Garabedian CEO XontogenyLou Lieto Partner Wilson SonsiniMuhammet Tanc Co-founder & CEO, Nuclide TherapeuticsJo Viney Cofounder, President & CEO Seismic TherapeuticNadine Beauger Sr Dir – Therapeutic & Medical Device Accelerator Boston Children’s HospitalJulien Pham Founder & Managing Partner Third Culture CapitalSarah Cork Managing Partner Cork Maloney LLP Bob Coughlin Managing Director, JLLVas Bailey General Partner AnomalyStephen Linderman CEO Absco Therapeutics, Inc.Lara Zibners Co-founder, Chair Calla Lily Clinical CareLeonard Smith Tax Partner WithumReginald Swift Founder & CEO Rubix LSMatt Lanchantin Strategic Partnerships Edison ScientificAkhila Kosaraju Co-founder & CEO, Phare BioLida Kourita Physician Gladstone InstitutesMichal Preminger CEO BioMed X Venture LabsBrock Reeve CEO Eos BioInnovationChandra Ramanathan Board Chair NucleateJohn Cumbers Founder & CEO SynBioBetaSamuel Kessel VICE PRESIDENT Locust WalkJeffrey Koury President ResearchHub FoundationAdam Jenkins Regional Director BioLabsSheila Gujrathi Managing Director SilverArc capitalCheri Ackerman Araromi CEO Concerto BiosciencesDeanna Angello Founder & President, Alpenglow Ventures LLCBen Kromnick General Manager RhoFrancesca Devine Co-Founder, Managing Partner Devine Insights GroupKristina Wang Principal and Founder Mulberry BioVenturesWarren Browne Partner Citrin CoopermanJosie Kishi Co-Founder Digital BiologyMichael Gibson General Partner, Co-founder, 1517 FundLauren Wilcoxen SVP, Regulatory Affairs Xilio TherapeuticsDan Ahlstedt Co-founder & COO EnPlusOne BioDan Goddard Director CFGOTere Williams CEO DUB TherapeuticsMandi Williams Contract Specialist WashU St. Louis
Join the Council
We invite you to become a founding member of the leadership council.
“Participating in Nucleate was critical in helping us prioritize our efforts and forge a path to get the company started. I don’t think we would have been as successful without the resources provided by the accelerator program and the people who helped along the way.”
– IVANA VASIC CEO, VITRA LABS
“Nucleate was so transformational—it changed my life, my career choices, and how I think about problem-solving and scaling organizations. You just don’t get this kind of experience in grad school.”
– MICHAEL RETCHIN FORMER CO-PRESIDENT, NUCLEATE CEO, SCALE MEDICINE
“We can’t lead in biotech if we cut the legs out from under early-stage innovation. Programs like Nucleate are important — they keep the pipeline alive by empowering young scientists to turn bold ideas into real breakthroughs.
That’s the kind of future we should be investing in.”
– CONGRESSMAN JAKE AUCHINCLOSS MASSACHUSETTS, FOURTH DISTRICT
Build the future of biotech with us.
Your Support Matters
Your support is a direct investment in the discoveries, therapies, and companies that will shape humanity’s future.
